Trial intelligence / Profile preview

Fluconazole versus Micafungin in neonates with suspected or culture-proven Candidiasis

2012-001916-41Phase 2Completed

Sponsor
Inserm
Start
Jun 2014
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in candidiasis comparing Fluconazole arm with Micafungin arm (2 arms). Primary endpoint: PK/PD integration of pharmacokinetics and pharmacodynamics. Started Jun 2014; status: completed.

02

Drugs

fluconazolemicafungin
03

Conditions

candidiasis

Beyond the preview

Go deeper on 2012-001916-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001916-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call